CINECA IRIS Institutional Research Information System

GIORGI, MARIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 20.299
EU - Europa 8.512
AS - Asia 3.953
SA - Sud America 510
OC - Oceania 245
AF - Africa 181
Continente sconosciuto - Info sul continente non disponibili 14
Totale 33.714
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 19.393
IT - Italia 2.631
CN - Cina 1.806
PL - Polonia 966
SE - Svezia 959
BG - Bulgaria 934
CA - Canada 760
GB - Regno Unito 684
DE - Germania 554
SG - Singapore 512
VN - Vietnam 430
TR - Turchia 410
UA - Ucraina 394
FI - Finlandia 345
BR - Brasile 261
AU - Australia 216
CH - Svizzera 210
IN - India 205
RU - Federazione Russa 162
CL - Cile 129
HK - Hong Kong 122
MX - Messico 112
ES - Italia 107
FR - Francia 96
NL - Olanda 93
JP - Giappone 70
IE - Irlanda 68
BD - Bangladesh 60
IR - Iran 60
KR - Corea 53
AT - Austria 52
PT - Portogallo 52
BE - Belgio 43
CI - Costa d'Avorio 42
GR - Grecia 41
TH - Thailandia 41
ID - Indonesia 40
EG - Egitto 38
RO - Romania 36
TW - Taiwan 35
CO - Colombia 34
AR - Argentina 30
PE - Perù 30
NZ - Nuova Zelanda 29
SN - Senegal 23
ZA - Sudafrica 21
PK - Pakistan 18
IL - Israele 15
NG - Nigeria 15
CR - Costa Rica 14
DK - Danimarca 14
CZ - Repubblica Ceca 13
HU - Ungheria 13
MY - Malesia 13
EC - Ecuador 12
EU - Europa 12
IQ - Iraq 11
SA - Arabia Saudita 10
BJ - Benin 9
VE - Venezuela 9
AE - Emirati Arabi Uniti 8
KH - Cambogia 8
LV - Lettonia 8
DZ - Algeria 7
JO - Giordania 7
LT - Lituania 7
MA - Marocco 7
ET - Etiopia 6
HR - Croazia 6
PA - Panama 6
PH - Filippine 6
GT - Guatemala 5
KE - Kenya 5
RS - Serbia 5
SK - Slovacchia (Repubblica Slovacca) 5
GL - Groenlandia 4
KZ - Kazakistan 4
MK - Macedonia 4
TN - Tunisia 4
UY - Uruguay 4
BN - Brunei Darussalam 3
LY - Libia 3
AP - ???statistics.table.value.countryCode.AP??? 2
BY - Bielorussia 2
EE - Estonia 2
FO - Isole Faroe 2
GP - Guadalupe 2
LK - Sri Lanka 2
AL - Albania 1
AN - Antille olandesi 1
BZ - Belize 1
LU - Lussemburgo 1
MV - Maldive 1
NO - Norvegia 1
NP - Nepal 1
PR - Porto Rico 1
PY - Paraguay 1
QA - Qatar 1
SC - Seychelles 1
SI - Slovenia 1
Totale 33.713
Salva come PNG Salva come JPEG
Città #
Woodbridge 3.020
Ann Arbor 1.961
Houston 1.799
Fairfield 1.735
Chandler 1.355
Sofia 932
Milan 925
Ashburn 864
Seattle 731
Beijing 702
Wilmington 701
Cambridge 616
New York 601
Jacksonville 596
Ottawa 579
Princeton 467
Serra 462
Boardman 421
Lawrence 379
Izmir 354
Nanjing 331
Medford 328
Redwood City 264
Singapore 215
Des Moines 201
Bern 179
Dearborn 141
Dong Ket 134
Nanchang 120
Menlo Park 114
Hong Kong 111
Jüchen 108
San Diego 106
Rome 91
London 89
Boulder 81
Falls Church 81
Shenyang 79
Montréal 71
Hebei 64
Kunming 64
Santiago 61
Khulna 58
Ogden 58
Ames 54
Tianjin 52
Changsha 50
Hefei 45
Norwalk 44
Guangzhou 43
Jiaxing 43
Abidjan 42
Vienna 42
Pune 41
Frankfurt am Main 40
Mcallen 40
Sydney 40
Hangzhou 34
Pisa 34
Munich 31
Washington 30
Pietrasanta 29
Los Angeles 28
Melbourne 28
São Paulo 28
Mumbai 27
Tokyo 27
Mexico City 26
Brisbane 25
Canberra 23
Dakar 23
Bari 22
Dallas 22
Florence 22
Brussels 21
Davis 20
Manchester 20
Athens 19
Indiana 19
Lappeenranta 19
Tacoma 19
Auburn Hills 18
Lima 18
Marseille 18
Orange 18
Bogotá 17
Bremen 17
Madison 17
Madrid 17
San Francisco 17
Bathurst 16
Curitiba 16
Tappahannock 16
Amsterdam 15
Birmingham 15
Bristol 15
Cairo 15
Hyderabad 15
Jinan 15
Phoenix 15
Totale 23.831
Salva come PNG Salva come JPEG
Nome #
Trazodone: A review of its pharmacological properties and its off-label use in dogs and cats 2.536
DEVELOPMENT AND VALIDATION OF A NEW HPLC-FLUORIMETRIC METHOD TO DETERMINE EPIRUBICIN AND ITS METABOLITEEPIRUBICINOL IN DOG PLASMA 978
ANTINOCICEPTIVE PROPERTIES OF HYDRO ALCOHOLIC EXTRACTS OF ANETHUM GRAVEOLENS L. (DILL) SEED AND AERIAL PARTS IN MICE 336
BIOPHARMACEUTICS OF METOCLOPRAMIDE: INTRAVENOUS, INTRAMUSCULAR, SUBCUTANEOUS AND PER RECTUM ADMINISTRATIONS IN RABBITS 282
CJ-023,423 (Grapiprant) a potential novel active compound with antihyperalgetic properties for veterinary patients 223
Novel LC-MS/MS method for CJ-023423 (Grapiprant) determination in rabbit plasma 217
A BRIEF OVERVIEW OF THE COXIB DRUGS IN THE VETERINARY FIELD 203
Pilot in vivo investigation of cerium oxide nanoparticles as a novel anti-obesity pharmaceutical formulation 181
PHARMACOKINETIC/PHARMACODYNAMIC ASSESSMENTS OF 10 MG/KG TRAMADOL INTRAMUSCULAR INJECTION IN YELLOW-BELLIED SLIDER TURTLES (TRACHEMYS SCRIPTA SCRIPTA). 176
EVALUATION OF PLASMA DETECTABLE CONCENTRATIONS OF TWO LIDOCAINE TRANSDERMAL FORMULATIONS AND THEIR ANALGESIC EFFECT IN THE HORSE 170
First-line metronomic chemotherapy in a metastatic model of spontaneous canine tumours: a pilot study 163
Clinical, pharmacodynamic and pharmacokinetic results of a prospective phase II study on oral metronomic vinorelbine and dexamethasone in castration-resistant prostate cancer patients 161
A NEW HPLC METHOD FOR THALIDOMIDE DETECTION IN HUMAN PLASMA 160
MIRTAZAPINE IN BEAGLE DOGS 160
Bioanalytical Method Validation and Quantification of Flupirtine in Canine Plasma by HPLC with Spectrofluorimetric Detection 156
USE OF A LASERCYTE® FOR THE COMPLETE BLOOD COUNT IN DOGS WITH ONCOHEMATOLOGICAL DISORDERS 152
PILOT IN VIVO TOXICOLOGICAL INVESTIGATION OF BORON NITRIDE NANOTUBES 149
Pharmacokinetic and pharmacodynamic evaluations of levofloxacin in broiler chickens 142
Pharmacokinetic/pharmacodynamic evaluation of grapiprant in a carrageenan-induced inflammatory pain model in the rabbit 142
INULIN BASED HYDROGEL FOR ORAL DELIVERY OF FLUTAMIDE: PREPARATION, CHARACTERIZATION AND IN VIVO RELEASE STUDIES 140
COMPARISON OF INJECTABLE PARECOXIB VERSUS ROBENACOXIB FOR PERI-OPERATIVE USE IN DOGS: PRELIMINARY RESULTS 139
Anticonvulsant activity of hydroalcoholic phoenix dactylifera fruit extract and pimpinella anisum oil in mice 139
Natural substances as new potential strategies for the treatment of Leishmaniosisin Dogs 137
PHARMACOKINETICS AND PHARMACODYNAMICS OF ZOLPIDEM AFTER ORAL ADMINISTRATION OF A SINGLE DOSE IN DOGS 136
ABNORMAL FINDINGS IN HAEMOGRAMS OF DACHSHUND PUPPIES: PRESUMPTIVE (IMMUNODEFICIENCY) FAMILIAL DISEASE 136
Nutlin-loaded magnetic solid lipid nanoparticles for targeted glioblastoma treatment 136
QUANTIFICATION OF TAPENTADOL IN CANINE PLASMA BY HPLC WITH SPECTROFLUORIMETRIC DETECTION: DEVELOPMENT AND VALIDATION OF A NEW METHODOLOGY 134
PHARMACOKINETICS OF METHYLPHENIDATE AFTER ORAL ADMINISTRATION OF IMMEDIATE AND SUSTAINED RELEASE PREPARATIONS IN BEAGLE DOGS 133
Pharmacokinetics of Sulpiride Following Intravenous, Intramuscular and Oral Single Dose Administration in Nurse Mares 132
BIOCOMPATIBILITY OF BORON NITRIDE NANOTUBES: AN UP-DATE OF IN VIVO TOXICOLOGICAL INVESTIGATION 131
A BRIEF OVERVIEW OF OUR CURRENT UNDERSTANDING OF NIVALENOL: A GROWING POTENTIAL DANGER YET TO BE FULLY INVESTIGATED 130
Effects of liquid and freeze-dried grapefruit juice on the pharmacokinetics of praziquantel and its metabolite 4′-hydroxy praziquantel in beagle dogs 129
BIOGENIC AMINE CONTENT IN “PECORINO DEL PARCO DI MIGLIARINO - SAN ROSSORE” 128
Analytical Method Validation of Vilazodone with Spectrofluorimetric Detection in Rabbit Plasma 127
CLINICAL INTERACTION BETWEEN GRAPEFRUIT-JUICE AND CYCLOSPORINE: IS THERE ANY INTEREST FOR VETERINARY MEDICINE? 123
EVALUATION OF TRAMADOL AND ITS MAIN METABOLITES IN HORSES PLASMA BY HPLC-FL AND LC-ESI-MS/MS TECHNIQUES 123
PHARMACOKINETICS OF METHYLPHENIDATE FOLLOWING TWO ORAL FORMULATIONS (IMMEDIATE AND SUSTAINED RELEASE) IN THE DOG 123
Pharmacokinetic Assessment of the Marker Active Metabolites 4-Methyl-amino-antipyrine and 4-Acetyl-amino-antipyrine After Intravenous and Intramuscular Injection of Metamizole (Dipyrone) in Healthy Donkeys 123
Pharmacokinetics of Metoclopramide After IntraARTERIAL, Intramuscular, Subcutaneous, and Perrectal Administration in Rabbits 122
Pharmacokinetic and pharmacodynamic evaluations of a 10 mg/kg enrofloxacin intramuscular administration in bearded dragons (Pogona vitticeps): A preliminary assessment 122
LABORATORY DIAGNOSTIC EXAMINATIONS IN VETERINARY TOXICOLOGY 121
Pharmacokinetics and disposition of flupirtine in the horse 121
PHARMACOKINETICS OF INTRAVENOUS AND INTRAMUSCULAR PARECOXIB IN HEALTHY BEAGLES 120
ANIMAL POISONING FREQUENCY IN CENTRAL ITALY (YEARS 2003-2004) 119
MIRTAZAPINE IN VETERINARY MEDICINE A PHARMACOLOGICAL RATIONALE FOR ITS APPLICATION IN CHRONIC PAIN 119
ORAL ADMINISTRATION OF TEPOXALIN IN THE HORSE: A PK/PD STUDY 119
Pharmacokinetics and estimated bioavailability of grapiprant, a novel selective prostaglandin E2 receptor antagonist, after oral administration in fasted and fed dogs 119
PHARMACOKINETIC INVESTIGATIONS OF THE MARKER ACTIVE METABOLITE-4-METHYLAMINO-ANTIPYRIN AFTER INTRAVENOUS AND INTRAMUSCULAR INJECTION OF METAMIZOLE IN HEALTHY SHEEP 119
PHARMACOKINETICS OF MIRTAZAPINE AND ITS MAIN METABOLITES AFTER SINGLE INTRAVENOUS AND ORAL ADMINISTRATIONS IN RATS AT TWO DOSE RATES 117
Apoptosis and gene expression in Jurkat human T cells and lymphoid tissues of fusarenon-X-treated mice 117
Pharmacokinetics of marbofloxacin in freshwater crocodiles (Crocodylus siamensis) after intravenous and intramuscular administration 117
Dispositions of enrofloxacin and its major metabolite ciprofloxacin in Thai swamp buffaloes 117
DETECTION AND QUANTIFICATION OF CIMICOXIB, A NOVEL COX-2 INHIBITOR, IN CANINE PLASMA BY HPLC WITH SPECTROFLUORIMETRIC DETECTION: DEVELOPMENT AND VALIDATION OF A NEW METHODOLOGY 116
PHARMACOKINETIC PROFILES OF THE NOVEL COX-2 SELECTIVE INHIBITOR CIMICOXIB IN DOGS 115
A new HPLC method to determine glomerular filtration rate and effective renal plasma flow in conscious dogs by single intravenous administration of iohexol and p-aminohippuric acid 115
Simultaneous detection and quantification of parecoxib and valdecoxib in canine plasma by HPLC with spectrofluorimetric detection: development and validation of a new methodology. 115
PHARMACOKINETCIS STUDY OF CLAZURIL (APPERTEX®) IN EGGS AND PLASMA FROM LAYING HENS AFTER SINGLE AND MULTIPLE TREATMENT BY A NEW HPLC METHOD 114
DEVELOPMENT AND VALIDATION OF A NEW GC-MS METHOD FOR DETECTION OF TRAMADOL, O-DESMETHYLTRAMADOL, 6-ACETYLMORPHINE AND MORPHINE IN BLOOD, BRAIN, LIVER, AND KIDNEY OF WISTAR RATS TREATED WITH THE COMBINATION OF HEROIN AND TRAMADOL 114
Pharmacokinetics of levosulpiride after single-dose administration by different routes in sheep (Ovis aries Linnaeus) 114
PHARMACOKINETICS OF THE NOVEL ATYPICAL OPIOID TAPENTADOL FOLLOWING ORAL AND INTRAVENOUS ADMINISTRATION IN DOGS 112
Role of Natural Products in Ameliorating Drugs and Chemicals Toxicity 112
Paracetamol: A Focus on Dogs 112
A comparative kinetic study of thiamphenicol in pre-ruminant lambs and calves 111
IN SITU FORMING GEL LIKE DEPOT OF A POLYASPARTAMIDE-POLYLACTIDE COPOLYMER FOR ONCE A WEEK ADMINISTRATION OF SULPIRIDE 111
PHARMACOKINETICS OF MIRTAZAPINE AND ITS MAIN METABOLITES AFTER SINGLE ORAL ADMINISTRATION IN FASTING/FED HORSES 110
The role of clomipramine in potentiating the teratogenic effects of caffeine in pregnant rats: a histopathological study 110
CONSTRUCTION AND EVALUATION OF SPONGE SCAFFOLDS FROM HYALURONIC ACID DERIVATIVES FOR POTENTIAL CARTILAGE REGENERATION 110
TREATMENT OF CANINE LYMPHOMA AS A MODEL FOR HUMANS 109
PHARMACOKINETIC PROFILES OF THE ANALGESIC DRUG FLUPIRTINE IN CATS 109
Clinical studies of metronomic chemotherapy in dogs 109
Disposition of a long-acting oxytetracycline formulation in Thai swamp buffaloes (Bubalus bubalis) 109
BLOOD CONCENTRATION OF ENROFLOXACIN AND ITS METABOLITE CIPROFLOXACIN IN YELLOW-BELLIED SLIDER TURTLES (TRACHEMYS SCRIPTA SCRIPTA), AFTER A SINGLE INTRACOELOMIC INJECTION OF ENROFLOXACIN 108
CHARACTERIZATION OF IN VIVO PLASMA METABOLITES OF TEPOXALIN IN HORSES USING LC-MS-MS 108
PHARMACOKINETIC EVALUATION OF TRAMADOL AND ITS MAJOR METABOLITES AFTER SINGLE ORAL SUSTAINED TABLET ADMINISTRATION IN THE DOG: A PILOT STUDY 108
THE PHARMACOKINETICS AND IN VITRO/EX VIVO CYCLOOXYGENASE SELECTIVITY OF PARECOXIB AND ITS ACTIVE METABOLITE VALDECOXIB IN CATS 108
PHARMACOKINETIC AND PHARMACODYNAMIC EVALUATIONS OF LEVOFLOXACIN IN BROILER CHICKENS 107
Pharmacokinetics of meloxicam in lactating goats (Capra hircus) and its quantification in milk after a single intravenous and intramuscular injection 107
Determination of tramadol and metabolites by HPLC-FL and HPLC-MS/MS in urine of dogs 107
ASSESSMENT OF THE PHARMACOKINETIC PROFILE OF TRAMADOL AND ITS MAIN METABOLITES IN PLASMA AND URINE FORM DOGS ORALLY ADMINISTERED WITH CONTRAMAL®, WITH OR WITHOUT FREEZE-DRIED GRAPE-FRUIT JUICE 106
Effects of liquid and freeze-dried grapefruit juice on the pharmacokinetics of praziquantel and its metabolite 4 '-hydroxy praziquantel in beagle dogs 106
The anti-inflammatory and antipyretic effects of clove oil in healthy dogs after surgery 106
CAN TEPOXALIN BE A SUITABLE NSAID IN THE HORSE? A PK/PD STUDY 105
BIOPHARMACEUTICAL PROFILE OF TRAMADOL IN THE DOG 105
SYNERGISTIC INTERACTION BETWEEN TAPENTADOL AND FLUPIRTINE IN THE RAT ORAFACIAL FORMALIN TEST 105
A NEW HIGH-PERFORMANCE LIQUID CHROMATOGRAPHIC METHOD FOR THE DETERMINATION OF IOHEXOL AND p-AMINOHIPPURIC ACID IN PLASMA OF DOGS 104
EU PERSPECTIVES OF BIOEQUIVALENCE TEST FOR THE APPROVAL OF GENERIC VETERINARY MEDICINAL PRODUCTS. THE ROLE OF EXCIPIENTS 104
Validation of an HPLC-FL method for the determination of tepoxalin and its major metabolite in horse plasma 104
DETECTION AND QUANTIFICATION OF THE SELECTIVE EP4 RECEPTOR ANTAGONIST CJ-023423 (GRAPIPRANT) IN CANINE PLASMA BY HPLC WITH SPECTROFLUORIMETRIC DETECTION 104
PHARMACOKINETICS OF DIFFERENT FORMULATIONS OF TRAMADOL IN THE HORSE 103
A NEW RAPID PROCEDURE TO DETECT BY HPLC-FL TRAMADOL AND ITS MAIN METABOLITES IN URINE 103
TRAMADOL AND TAPENTADOL HYDROCLORYDE: AN OLD AND A NOVEL ATYPICAL OPIOID DRUG. AN OVERVIEW ON THEIR PRESENT AND POTENTIAL APPLICATIONS. 103
TANAX (T61) AN OVERVIEW 103
Synergistic interaction between tapentadol and flupirtine in the rat orafacial formalin test 103
Cardiovascular effects and intraoperative pharmacokinetics of tramadol in sheep undergoing spinal surgery 103
IN VITRO METABOLISM OF TRAMADOL IN HORSES: PRELIMINARY DATA 102
PHARMACOKINETICS AND ANTINOCICEPTIVE EFFECTS OF TRAMADOL AND ITS METABOLITE O-DESMETHYLTRAMADOL FOLLOWING INTRAVENOUS ADMINISTRATION IN SHEEP 102
CLINICAL AND HEMATOLOGICAL ADVERSE EFFECTS AFTER ADMINISTRATION OF TWO DIFFERENT CHEMOTHERAPY PROTOCOLS IN DOGS AFFECTED BY LYMPHOMA 102
Toxicokinetic profile of fusarenon-X and its metabolite nivalenol in the goat (Capra hircus) 102
Toxicokinetics and tissue distribution of nivalenol in broiler chickens 102
PK-PD INTEGRATION/MODELING OF NSAID IN VETERINARY PHARMACOLOGY 101
Totale 16.013
Salva come PNG Salva come JPEG
Categoria #
all - tutte 86.566
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 86.566
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20203.896 0 0 356 307 425 445 576 359 495 360 472 101
2020/20213.817 333 295 205 229 332 357 187 330 400 283 264 602
2021/20224.397 149 304 155 303 720 604 134 251 215 160 268 1.134
2022/20233.898 548 364 298 385 513 565 88 295 564 34 188 56
2023/20246.088 622 547 526 402 668 782 218 328 136 1.089 309 461
2024/2025753 135 546 72 0 0 0 0 0 0 0 0 0
Totale 34.653